Back to Search
Start Over
Non-mutagenic Ru(<scp>ii</scp>) complexes: cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding
- Source :
- Scopus, Repositório Institucional da UNESP, Universidade Estadual Paulista (UNESP), instacron:UNESP, Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual), Universidade de São Paulo (USP), instacron:USP
- Publication Year :
- 2019
- Publisher :
- Royal Society of Chemistry (RSC), 2019.
-
Abstract
- Made available in DSpace on 2020-12-12T01:40:44Z (GMT). No. of bitstreams: 0 Previous issue date: 2019-01-01 Herein we discuss five ruthenium(ii) complexes with good cytotoxicity against cancer cells. These complexes are named [Ru(tzdt)(bipy)(dppb)]PF6 (1), [Ru(mmi)(bipy)(dppb)]PF6 (2), [Ru(dmp)(bipy)(dppb)]PF6 (3), [Ru(mpca)(bipy)(dppb)]PF6 (4) and [Ru(2mq)(bipy)(dppb)]PF6 (5), where tzdt = 1,3-thiazolidine-2-thione, mmi = mercapto-1-methyl-imidazole, dmp = 4,6-diamino-2-mercaptopyrimidine, mpca = 6-mercaptopyridine-3-carboxylic acid, 2mq = 2-mercapto-4(3H)-quinazolinone, bipy = 2,2′-bipyridine and dppb = 1,4-bis(diphenylphosphino)butane. In vitro cell culture experiments revealed significant cytotoxic activity for 1-5 against MDA-MB-231, MCF-7, A549, DU-145 and HepG2 tumor cells, higher than that for the standard anticancer drug cisplatin. Compound/DNA interaction studies were carried out showing that 1-5 interact with DNA by electrostatic force of attraction or by hydrogen bonding. Moreover, the complexes interact, moderately and spontaneously, with human serum albumin (HSA) through the hydrophobic region. The five complexes are able to inhibit the DNA supercoiled relaxation mediated by human topoisomerase IB (TopIB), and complex 1 is found to be the most efficient TopIB inhibitor among the five compounds. The inhibitory effect and analysis of different steps of the TopIB catalytic cycle indicate that complex 1 inhibits the cleavage reaction impeding the binding of the enzyme to DNA and has no effect on the religation step. Complexes 1, 2 and 3 did not show mutagenic activity when they were evaluated by the cytokinesis-block micronucleus cytome assay in HepG2 cells and the Ames test in the presence and absence of mouse liver S9 metabolic activation. Therefore, it is necessary to perform further in-depth analysis of the therapeutic potential of these promising ruthenium complexes as anticancer drugs. Dipartimentodi Biologia UniversitàTorVergatadi Roma Departamento de Química Universidade Federal de São Carlos, CP 676 Departamento de Química Universidade Federal de Ouro Preto Departamento de Ciências Biológicas Faculdade de Ciências Farmacêuticas UNESP Instituto de Física Universidade DeSão Paulo, CP 369 Instituto de Química de São Carlos Universidade de São Paulo, CP 780 Departamento de Gerontologia Universidade Federal de São Carlos, CP 676 Departamento de Ciências Biológicas Faculdade de Ciências Farmacêuticas UNESP
- Subjects :
- Stereochemistry
chemistry.chemical_element
Antineoplastic Agents
Ames test
Inorganic Chemistry
chemistry.chemical_compound
Coordination Complexes
Neoplasms
Tumor Cells, Cultured
medicine
Humans
Settore BIO/10
Cytotoxicity
Micronuclei, Chromosome-Defective
chemistry.chemical_classification
biology
Topoisomerase
DNA
RUTÊNIO
Human serum albumin
Ruthenium
Enzyme
chemistry
Catalytic cycle
Cytoprotection
biology.protein
Ruthenium Compounds
Topoisomerase I Inhibitors
medicine.drug
Subjects
Details
- ISSN :
- 14779234 and 14779226
- Volume :
- 48
- Database :
- OpenAIRE
- Journal :
- Dalton Transactions
- Accession number :
- edsair.doi.dedup.....53d8fb2c32348bad8e09e44ff17a14c5
- Full Text :
- https://doi.org/10.1039/c9dt01905g